?? IELs are located within the intestinal epithelial monolayer, and the close proximity of these cells to the intestinal lumen positions ?? IELs to ac as immediate responders to enteric pathogens. In the absence of ??IELs, translocation of both commensal bacteria and enteric pathogens is enhanced, demonstrating the unique ability of ?? IELs to bridge innate and adaptive immunity. This innate immune function is demonstrated by the crosstalk that occurs between intestinal epithelial cells and ?? IELs to promote the release f anti-microbial factors in response to Salmonella infection. I have reported that ?? IEL migration provides continuous surveillance of the villous epithelium in an occludin-dependent manner and that this motility is sufficient to limit S. typhimurium translocation; however, the role of ?? IL migration and subsequent epithelial interactions in the activation of innate immunity remains unknown. During my K01 studies, I developed the tools necessary to assess and genetically modulate ?? IEL/epithelial interactions in response to an enteric pathogen. Building on these novel approaches, the proposed R03 studies will begin to identify the cellular mechanism(s) by which ?? IELs and their interactions with epithelial cells promote an immediate innate immune response to prevent bacterial translocation. My central hypothesis is that ??IEL migration and subsequent epithelial interactions are necessary for the immediate production of soluble mediators involved in innate immunity. To test this hypothesis, I will first determine the requirement for occludin-dependent ?? IEL migration on ?? IEL and epithelial cell production of soluble immune mediators and then assess the cellular mechanisms by which these soluble factors contribute to ??IEL-mediated protection against bacterial invasion. These studies will provide new mechanistic insights into the functional role of ?? IELs as the first line of defense against luminal pathogens. The results are expected to serve as the foundation for future study of how ?? IELs mediate an innate immune response to commensal bacteria or in the context of defective host pathogen recognition responses in intestinal diseases such as IBD. This may lead to new strategies to assess ?? IEL/epithelial interactions and function within the intestina mucosa as means to treat disease.

Public Health Relevance

The proposed research is relevant to public health because it will discern the functional consequence of direct ?? IEL/epithelial interactions to not only investigate ?? IEL function in innate immunity, but also to provide strategies for the direct stuy of ?? IEL/epithelial interactions in patients with intestinal disorders such as inflammatory bowe disease or celiac disease. This essential knowledge is required to develop new strategies to asses ?? IEL/epithelial interactions and function within the intestinal mucosa as means to treat disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Research Grants (R03)
Project #
1R03DK106484-01
Application #
8953798
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Saslowsky, David E
Project Start
2015-09-30
Project End
2017-06-30
Budget Start
2015-09-30
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Rutgers University
Department
Pathology
Type
Schools of Medicine
DUNS #
078795851
City
Newark
State
NJ
Country
United States
Zip Code
Hu, Madeleine D; Ethridge, Alexander D; Lipstein, Rebecca et al. (2018) Epithelial IL-15 Is a Critical Regulator of ?? Intraepithelial Lymphocyte Motility within the Intestinal Mucosa. J Immunol 201:747-756
Hu, Madeleine D; Jia, Luo; Edelblum, Karen L (2018) Policing the intestinal epithelial barrier: Innate immune functions of intraepithelial lymphocytes. Curr Pathobiol Rep 6:35-46
Hu, Madeleine D; Edelblum, Karen L (2017) Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease. Curr Pharmacol Rep 3:321-334
Edelblum, Karen L (2016) Dissecting the Requirement for Secondary Lymphoid Organs in Peripheral Regulatory T-Cell Development. Cell Mol Gastroenterol Hepatol 2:253-254